Alain Enjalbert Selected Research

Combined Pituitary Hormone Deficiency

6/2016	MECHANISMS IN ENDOCRINOLOGY: An update in the genetic aetiologies of combined pituitary hormone deficiency.
12/2006	Identification and functional analysis of the novel S179R POU1F1 mutation associated with combined pituitary hormone deficiency.
12/2006	Involvement of the pituitary-specific transcription factor pit-1 in somatolactotrope cell growth and death: an approach using dominant-negative pit-1 mutants.
9/2006	Genetic screening of combined pituitary hormone deficiency: experience in 195 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alain Enjalbert Research Topics

Disease

10	Neoplasms (Cancer) 01/2016 - 05/2007
6	Pituitary Neoplasms (Pituitary Adenoma) 03/2011 - 07/2003
5	Growth Hormone-Secreting Pituitary Adenoma 01/2016 - 10/2004
5	Adenoma (Adenomas) 01/2016 - 02/2002
4	Hypopituitarism (Sheehan's Syndrome) 06/2017 - 03/2004
4	Combined Pituitary Hormone Deficiency 06/2016 - 09/2006
2	Common Variable Immunodeficiency 12/2014 - 01/2012
2	Prolactinoma (Prolactinomas) 05/2012 - 05/2007
2	Infections 01/2012 - 12/2008
2	Pheochromocytoma 04/2011 - 05/2009
2	Paraganglioma (Paragangliomas) 04/2011 - 05/2009
1	Meningioma (Meningiomas) 08/2015
1	Macroglossia 04/2015
1	Pseudohypoparathyroidism 04/2015
1	Hypothyroidism 01/2015
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2014
1	Primitive Neuroectodermal Tumors (PNET) 10/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2014
1	Body Weight (Weight, Body) 01/2013
1	Delayed Puberty 12/2012
1	Familial Isolated Pituitary Adenoma 06/2012
1	Reinfection 01/2012
1	Hypoglycemia (Reactive Hypoglycemia) 01/2012
1	Autoimmune Hypophysitis 01/2012
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2009
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2009
1	Carcinogenesis 05/2007
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2005
1	Perinatal Death 03/2005
1	ACTH-Secreting Pituitary Adenoma 07/2003
1	Hyperprolactinemia 02/2002

Drug/Important Bio-Agent (IBA)

7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2015 - 12/2008
6	ProlactinIBA 01/2016 - 07/2003
6	Octreotide (Sandostatin)FDA LinkGeneric 08/2015 - 09/2007
5	Transcription Factors (Transcription Factor)IBA 06/2017 - 03/2004
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2015 - 03/2005
4	Messenger RNA (mRNA)IBA 01/2016 - 07/2003
4	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2015 - 12/2008
4	Hormones (Hormone)IBA 12/2014 - 03/2004
3	Dopamine (Intropin)FDA LinkGeneric 05/2012 - 04/2011
3	Growth Hormone (Somatotropin)IBA 01/2012 - 12/2008
2	Glycoproteins (Glycoprotein)IBA 06/2016 - 10/2004
2	Pharmaceutical PreparationsIBA 08/2015 - 12/2014
2	Ghrelin ReceptorsIBA 12/2014 - 01/2013
2	Biological ProductsIBA 10/2014 - 02/2002
2	GonadotropinsIBA 12/2012 - 07/2003
1	Immunoglobulins (Immunoglobulin)IBA 06/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2016
1	pegvisomant FDA LinkGeneric 01/2016
1	Proteins (Proteins, Gene)FDA Link 08/2015
1	Neurofibromin 2 (Merlin)IBA 08/2015
1	Cyclin D1IBA 08/2015
1	Everolimus FDA Link 08/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2015
1	Parathyroid Hormone (Parathormone)IBA 04/2015
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2015
1	Substance PIBA 12/2014
1	GTP-Binding Proteins (G-Protein)IBA 10/2014
1	Chromogranin AIBA 10/2014
1	pasireotideIBA 10/2014
1	Cyclin-Dependent Kinase Inhibitor p27IBA 06/2012
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2012
1	TBR-760IBA 05/2012
1	Cabergoline FDA LinkGeneric 05/2012
1	Arginine (L-Arginine)FDA Link 01/2012
1	Tryptophan (L-Tryptophan)FDA Link 01/2012
1	Transcription Factor Pit-1 (Transcription Factor Pit 1)IBA 01/2012
1	Codon (Codons)IBA 09/2011
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2011
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 04/2011
1	Dopamine Receptors (Dopamine Receptor)IBA 04/2011
1	Radioisotopes (Radionuclides)IBA 04/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2009
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2009
1	Dihydrotachysterol (AT 10)IBA 12/2008
1	aryl hydrocarbon receptor-interacting proteinIBA 05/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2006
1	GlucocorticoidsIBA 03/2005
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 10/2004
1	enhanced green fluorescent proteinIBA 10/2004
1	Human Growth Hormone (Saizen)FDA LinkGeneric 10/2004
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 07/2003

Therapy/Procedure

5	Therapeutics 12/2014 - 02/2002
1	Drug Therapy (Chemotherapy) 08/2015
1	Ligation 05/2007